W Gregory Hundley1,2,3. 1. Department of Internal Medicine (Section on Cardiovascular Medicine), Wake Forest Health Sciences, Winston-Salem, NC, 27103, USA. ghundley@wakehealth.edu. 2. Department of Radiology, Wake Forest Health Sciences, Winston-Salem, NC, 27103, USA. ghundley@wakehealth.edu. 3. Wake Forest Health Sciences, Bowman Gray Campus, Medical Center Boulevard, Winston-Salem, NC, 27157-1045, USA. ghundley@wakehealth.edu.
Abstract
PURPOSE OF REVIEW: This article reviews the utility of cardiovascular magnetic resonance imaging (CMR) to detect abnormalities of the cardiovascular system that may result from cancer or its treatment. RECENT FINDINGS: With CMR, one may assess cardiac anatomy, function, myocardial perfusion, tissue composition, and blood flow. For those with cancer, these capabilities allow one to differentiate myocardial masses that may relate to the presence of cancer and evaluate diseases of the pericardium. These features facilitate measurement of left ventricular (LV) volumes, ejection fraction, mass, strain, T1 and T2 relaxation properties, and the extracellular volume fraction all of which may be useful for detecting subclinical cardiovascular injury that results from the receipt of potentially cardiotoxic cancer treatment. CMR can provide an effective and efficient means to identify clinical abnormalities resulting from the diagnosis of cancer or subclinical cardiac injury that may be related to receipt of the therapy for cancer.
PURPOSE OF REVIEW: This article reviews the utility of cardiovascular magnetic resonance imaging (CMR) to detect abnormalities of the cardiovascular system that may result from cancer or its treatment. RECENT FINDINGS: With CMR, one may assess cardiac anatomy, function, myocardial perfusion, tissue composition, and blood flow. For those with cancer, these capabilities allow one to differentiate myocardial masses that may relate to the presence of cancer and evaluate diseases of the pericardium. These features facilitate measurement of left ventricular (LV) volumes, ejection fraction, mass, strain, T1 and T2 relaxation properties, and the extracellular volume fraction all of which may be useful for detecting subclinical cardiovascular injury that results from the receipt of potentially cardiotoxic cancer treatment. CMR can provide an effective and efficient means to identify clinical abnormalities resulting from the diagnosis of cancer or subclinical cardiac injury that may be related to receipt of the therapy for cancer.
Entities:
Keywords:
Cancer; Cardiovascular magnetic resonance; Imaging
Authors: Sandra Fussen; Bart W L De Boeck; Michael J Zellweger; Jens Bremerich; Kaatje Goetschalckx; Michel Zuber; Peter T Buser Journal: Eur Heart J Date: 2011-04-15 Impact factor: 29.983
Authors: Pablo Pazos-López; Eduardo Pozo; Maria E Siqueira; Inés García-Lunar; Matthew Cham; Adam Jacobi; Frank Macaluso; Valentín Fuster; Jagat Narula; Javier Sanz Journal: JACC Cardiovasc Imaging Date: 2014-08-13
Authors: Edith Pituskin; John R Mackey; Sheri Koshman; Davinder Jassal; Marshall Pitz; Mark J Haykowsky; Joseph J Pagano; Kelvin Chow; Richard B Thompson; Larissa J Vos; Sunita Ghosh; Gavin Y Oudit; Justin A Ezekowitz; D Ian Paterson Journal: J Clin Oncol Date: 2016-11-28 Impact factor: 44.544
Authors: Jennifer H Jordan; Sujethra Vasu; Timothy M Morgan; Ralph B D'Agostino; Giselle C Meléndez; Craig A Hamilton; Andrew E Arai; Songtao Liu; Chia-Ying Liu; João A C Lima; David A Bluemke; Gregory L Burke; W Gregory Hundley Journal: Circ Cardiovasc Imaging Date: 2016-08 Impact factor: 7.792
Authors: Tomas G Neilan; Otavio R Coelho-Filho; Diego Pena-Herrera; Ravi V Shah; Michael Jerosch-Herold; Sanjeev A Francis; Javid Moslehi; Raymond Y Kwong Journal: Am J Cardiol Date: 2012-08-21 Impact factor: 2.778
Authors: Colin J Yi; Colin O Wu; Michael Tee; Chia-Ying Liu; Gustavo J Volpe; Martin R Prince; Gregory W Hundley; Antoinette S Gomes; Rob J van der Geest; Susan Heckbert; João A Lima; David A Bluemke Journal: J Cardiovasc Magn Reson Date: 2015-02-12 Impact factor: 5.364